Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases [Yahoo! Finance]
Eupraxia Pharmaceuticals Inc. (EPRX)
Company Research
Source: Yahoo! Finance
VICTORIA, BC Sept. 19, 2024 Edinburgh, Scotland on September 22-24, 2024 The event is a premier global conference focused on advancing knowledge and collaboration in the field of digestive endoscopy. Presentation Details: Paper Number: Presentation Title: PP02.05 Initial Results from RESOLVE, a Phase 1b Dose-Escalation Study of EP-104GI (Extended-Release Fluticasone Propionate Intra-Esophageal Injection) for Eosinophilic Esophagitis Presentation Type: Poster Presentation Theme: Benign Disease Session Date & Time: September 23, 2024, from 12:00 PM to 1:45 PM BST (7:00 AM to 8:45 AM ET) The presentation, which will feature data from cohorts one through four from the RESOLVE trial, will also be available on Eupraxia's website at: https://eupraxiapharma.com/our-science/clinical-trials-and-publications/default.aspx About Eupraxia Pharmaceuticals Inc. Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended
Show less
Read more
Impact Snapshot
Event Time:
EPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EPRX alerts
High impacting Eupraxia Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
EPRX
News
- Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal DiseasesPR Newswire
- Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic EsophagitisPR Newswire
- Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferencePR Newswire
- Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial ResultsPR Newswire
EPRX
Sec Filings
- 9/19/24 - Form 6-K
- 9/11/24 - Form 6-K
- 9/4/24 - Form 6-K
- EPRX's page on the SEC website